脂肪肝指数与慢性肾脏病的关联:基于人群的KORA研究
在德国KORA队列2920名参与者中,基线脂肪肝指数(FLI)≥60者占40.4%,慢性肾脏病(CKD)患病率为5.6%;平均随访6.5年间182人发生CKD。FLI与基于胱抑素C估算的肾小球滤过率(eGFR-cC)定义的CKD患病呈正相关,与CKD发病的正关联在调整代谢危险因素后减弱,并完全由炎症、糖尿病和高血压共同介导。
要点
- 基线FLI≥60者占40.4%,CKD患病率为5.6%,随访期间182人发生CKD。
- 横断面FLI与eGFR-cC定义的CKD患病正相关(OR 1.28,95%CI 1.01-1.61)。
- FLI与CKD发病的正关联完全由炎症、糖尿病和高血压共同介导。
核心结论
- FLI与CKD发病的正关联完全由代谢危险因素(炎症、糖尿病和高血压)的共同作用介导。
- 未来需开展纵向研究,通过重复测量探讨脂肪肝、心脏代谢危险因素与肾功能之间的时间先后相互作用。
研究设计与样本
- 基于人群的德国KORA队列研究,纳入2920名参与者(女性51.6%,平均年龄56.1岁),其中1991人平均随访6.5年(±0.3年)。
- 肾功能采用基于肌酐估算的肾小球滤过率(eGFR-Cr)或基于胱抑素C估算的肾小球滤过率(eGFR-cC)评估。
- 采用多元逻辑回归或线性回归评估FLI与肾功能及CKD(eGFR<60 ml/min/1.73 m2)的关联,并用中介分析探讨代谢因素的中介效应。
主要发现
- 基线时FLI≥60的患病率为40.4%,CKD患病率为5.6%,随访期间182名参与者发生CKD。
- 横断面上,FLI与eGFR-cC显著负相关(β=-1.14,95%CI -1.81至-0.47),与基于eGFR-cC的CKD患病正相关(OR 1.28,95%CI 1.01-1.61),与其他标志物无显著关联。
- 调整生活方式因素后,FLI与基于eGFR-cC或eGFR-Cr定义的CKD发病呈正关联,但在控制代谢危险因素后该关联减弱。
- 中介分析显示,该关联完全由炎症、糖尿病和高血压共同介导。
局限性
- 未来需开展纵向研究,通过重复测量探讨脂肪肝、心脏代谢危险因素与肾功能之间的时间先后相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to evaluate the relationship of fatty liver, estimated by the fatty liver index (FLI), with kidney function and chronic kidney disease (CKD) in a German cohort study, given the lack of prospective evidence in Europeans. METHODS: We included 2920 participants (51.6% women, mean age 56.1 years) from the KORA study, of which 1991 were followed up for an average of 6.5 years (± 0.3). Kidney function was assessed using the glomerular filtration rate estimated by creatinine (eGFR-Cr) or cystatin C (eGFR-cC). We used multiple logistic or linear regressions to evaluate the associations between the FLI, kidney function and CKD (eGFR < 60 ml/min/1.73 m2) and mediation analysis to explore the mediation effects of metabolic factors. RESULTS: The prevalence of FLI ≥60 and CKD was 40.4% and 5.6% at baseline, respectively, and 182 participants developed CKD during the follow-up. Cross-sectionally, FLI was significantly inversely associated with eGFR-cC {β = -1.14 [95% confidence interval (CI) -1.81 to -0.47]} and prevalent CKD based on eGFR-cC [OR 1.28 (95% CI 1.01-1.61)], but not with other markers. After adjusting for lifestyle factors, we found a positive association between FLI and incident CKD defined by eGFR-cC or/eGFR-Cr, which was attenuated after controlling for metabolic risk factors. Mediation analysis showed that the association was completely mediated by inflammation, diabetes and hypertension jointly. CONCLUSION: The positive association between FLI and CKD incidence was fully mediated by the joint effect of metabolic risk factors. Future longitudinal studies need to explore the chronological interplay between fatty liver, cardiometabolic risk factors and kidney function with repeated measurements.
引用
- Cai X, Thorand B, Hohenester S, et al. Association between the fatty liver index and chronic kidney disease: the population-based KORA study. Nephrol Dial Transplant. 2023. PMID: 36150717. doi:10.1093/ndt/gfac266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。